Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleImaging

α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States

Kritika Subramanian, Judith Stangl-Kremser, Lady Sawoszczyk, Vasilios Avlonitis, Andrew Gernerd, Kyla Nixon, Michael Zgaljardic, Scott Tagawa, Neil Bander and Joseph R. Osborne
Journal of Nuclear Medicine Technology September 2023, 51 (3) 215-219; DOI: https://doi.org/10.2967/jnmt.122.265166
Kritika Subramanian
1Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith Stangl-Kremser
2Department of Urology, Weill Cornell Medicine, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lady Sawoszczyk
1Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vasilios Avlonitis
1Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Gernerd
1Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyla Nixon
1Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Zgaljardic
3Department of Medical Health Physics, Weill Cornell Medicine, New York, New York; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Tagawa
4Division of Medical Oncology, Department of Oncology, Weill Cornell Medicine, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Bander
2Department of Urology, Weill Cornell Medicine, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph R. Osborne
1Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 51 no. 3 215-219
DOI 
https://doi.org/10.2967/jnmt.122.265166
PubMed 
37163648

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication November 11, 2022
  • Revision received February 12, 2023
  • Published online September 5, 2023.

Article Versions

  • previous version (April 25, 2023 - 07:38).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Kritika Subramanian1,
  2. Judith Stangl-Kremser2,
  3. Lady Sawoszczyk1,
  4. Vasilios Avlonitis1,
  5. Andrew Gernerd1,
  6. Kyla Nixon1,
  7. Michael Zgaljardic3,
  8. Scott Tagawa4,
  9. Neil Bander2 and
  10. Joseph R. Osborne1
  1. 1Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York;
  2. 2Department of Urology, Weill Cornell Medicine, New York, New York;
  3. 3Department of Medical Health Physics, Weill Cornell Medicine, New York, New York; and
  4. 4Division of Medical Oncology, Department of Oncology, Weill Cornell Medicine, New York, New York
  1. For correspondence or reprints, contact Kritika Subramanian (krs9089{at}nyp.org).
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2023 to May 2025

AbstractFullPdf
Apr 20234902615
May 20235511415
Jun 2023297104
Jul 2023120124
Aug 202320821
Sep 2023311126
Oct 20231984415
Nov 202314413331
Dec 2023625322
Jan 20241312813
Feb 2024683818
Mar 2024623127
Apr 2024455035
May 20241604518
Jun 20241232010
Jul 20241501011
Aug 20241372517
Sep 2024387455
Oct 2024246230
Nov 2024308846
Dec 2024106031
Jan 2025206241
Feb 2025168046
Mar 2025157041
Apr 20251410755
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 51 (3)
Journal of Nuclear Medicine Technology
Vol. 51, Issue 3
September 1, 2023
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States
Kritika Subramanian, Judith Stangl-Kremser, Lady Sawoszczyk, Vasilios Avlonitis, Andrew Gernerd, Kyla Nixon, Michael Zgaljardic, Scott Tagawa, Neil Bander, Joseph R. Osborne
Journal of Nuclear Medicine Technology Sep 2023, 51 (3) 215-219; DOI: 10.2967/jnmt.122.265166

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States
Kritika Subramanian, Judith Stangl-Kremser, Lady Sawoszczyk, Vasilios Avlonitis, Andrew Gernerd, Kyla Nixon, Michael Zgaljardic, Scott Tagawa, Neil Bander, Joseph R. Osborne
Journal of Nuclear Medicine Technology Sep 2023, 51 (3) 215-219; DOI: 10.2967/jnmt.122.265166
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • TECHNICAL AND PRODUCTION DETAILS
    • QUALITY CONTROL AND QUALITY ASSURANCE TESTING
    • RADIATION SAFETY
    • THERAPEUTIC ADMINISTRATION CONSIDERATIONS
    • CLINICAL CONSIDERATIONS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early 10-Minute Postinjection [18F]F-FAPI-42 uEXPLORER Total-Body PET/CT Scanning Protocol for Staging Lung Cancer Using HYPER Iterative Reconstruction
  • Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using 99mTc-Pyrophosphate
  • Does Arthrography Improve Accuracy of SPECT/CT for Diagnosis of Aseptic Loosening in Patients with Painful Knee Arthroplasty: A Systematic Review and Metaanalysis
Show more Imaging

Similar Articles

Keywords

  • radiochemistry
  • Radionuclide Therapy
  • radiopharmaceuticals
  • 225Ac
  • PSMA
  • α-particle
SNMMI

© 2025 SNMMI

Powered by HighWire